Targeting Notch signaling in autoimmune and lymphoproliferative disease
Open Access
- 15 January 2008
- journal article
- Published by American Society of Hematology in Blood
- Vol. 111 (2) , 705-714
Abstract
Patients with autoimmune lymphoproliferative syndrome (ALPS) and systemic lupus erythematosis (SLE) have T-cell dysregulation and produce abnormal, activated T lymphocytes and an atypical peripheral T-cell population, termed double negative T cells (DNTs). T-cell functions, including DNT transition in T-cell development and T-cell activation, are critically dependent on Notch signaling. We hypothesized that inhibiting Notch signaling would be effective in ALPS and SLE by reducing the production of abnormal DNTs and by blocking aberrant T-cell activation. We tested this hypothesis using murine models of ALPS and SLE. Mice were randomized to treatment with the notch pathway inhibitor (gamma-secretase inhibitor), N-S-phenyl-glycine-t-butyl ester (DAPT), or vehicle control. Response to treatment was assessed by measurement of DNTs in blood and lymphoid tissue, by monitoring lymph node and spleen size with ultrasound, by quantifying cytokines by bead-array, by ELISA for total IgG and anti–double-stranded DNA (dsDNA) specific antibodies, and by histopathologic assessment for nephritis. We found a profound and statistically significant decrease in all disease parameters, comparing DAPT-treated mice to controls. Using a novel dosing schema, we avoided the reported toxicities of gamma-secretase inhibitors. Inhibiting the Notch signaling pathway may thus present an effective, novel, and well-tolerated treatment for autoimmune and lymphoproliferative diseases.Keywords
This publication has 60 references indexed in Scilit:
- The expanded double negative T cell populations of a patient with ALPS are not clonally related to CD4+ or to CD8+ T cellsAutoimmunity, 2007
- Rapamycin improves lymphoproliferative disease in murine autoimmune lymphoproliferative syndrome (ALPS)Blood, 2006
- The requirement for Notch signaling at the β-selection checkpoint in vivo is absolute and independent of the pre–T cell receptorJournal of Experimental Medicine, 2006
- Notch 1 activation in the molecular pathogenesis of T-cell acute lymphoblastic leukaemiaNature Reviews Cancer, 2006
- Abnormal Fas/FasL and caspase-3-mediated apoptotic signaling pathways of T lymphocyte subset in patients with systemic lupus erythematosusCellular Immunology, 2006
- Prevention and reversal of nephritis in MRL/lpr mice with a single injection of C‐reactive proteinArthritis & Rheumatism, 2005
- Amelioration of autoimmune nephritis by imatinib in MRL/lpr miceArthritis & Rheumatism, 2005
- Acute γ-Secretase Inhibition Improves Contextual Fear Conditioning in the Tg2576 Mouse Model of Alzheimer's DiseaseJournal of Neuroscience, 2005
- Activating Mutations of NOTCH1 in Human T Cell Acute Lymphoblastic LeukemiaScience, 2004
- Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosisNature, 1992